Effects of rib raising on the autonomic regulation of the limbs
Phase 2
- Conditions
- M99.08M99.06M99.07
- Registration Number
- DRKS00017141
- Lead Sponsor
- Medifit Englert
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 45
Inclusion Criteria
18 to 65 years old, German Language
Exclusion Criteria
Acute back pain, trauma or surgery at the spine or rib cage area, osteoporosis, adipositas (BMI higher than 30), diseases of the blood vessels, the circulation, the nervous system, hypercholesterinaemie, arterial hypertension, diabetes, smoking, medication use
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Skin conduction (MentalBioScreen K3), Tone (MyotonPRO), Temperature (Fluke 62 Max+ and Greisinger); pre/post each
- Secondary Outcome Measures
Name Time Method Questionnaire
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link rib raising to autonomic limb regulation in DRKS00017141?
How does rib raising therapy compare to standard-of-care for autonomic dysfunction in M99.08 conditions?
Which biomarkers correlate with improved autonomic response to rib raising in Phase II trials?
What adverse events are reported in DRKS00017141 and how are they managed in rib raising interventions?
Are there combination therapies with rib raising and pharmacological agents for autonomic limb disorders?